Biocon Biologics at Chennai is a 56000 sq. ft RND centre equipped with end-to-end cutting-edge infrastructure involving upstream, downstream, formulation, analytical characterization, functional characterization, and pilot facilities. A world-class team is being put together to develop biosimilar therapies all the way through process development, characterization, scale-up, and technology transfer to feed into our large-scale manufacturing facilities at Bangalore. We are looking for passionate science-driven minds at all levels across different functions.

The leading edge of Hetero Group, Hetero Biopharma, is steadily establishing itself as a path breaking Biosimilar developer. As a strong R&D driven company offering some of the blockbuster Biosimilar Drugs, we at Hetero Biopharma are bringing about a paradigm shift in the way patients suffering from various chronic conditions are treated. Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide.

District Health Society, Zilla Panchayat, Taluka under the control of Vadodara. Vacancies at the Center and future vacancies are to be filled on temporary basis for 11 months contract based on the following posts as per the educational qualification mentioned against their names.

Post : Pharmacist

Centre for Cellular and Molecular Platforms (C-CAMP), is a Dept. of Biotechnology (Govt. of India) initiative and a not for profit organization based in Bangalore. We act as an enabler of Bioscience Research, Innovation and Entrepreneurship by providing Research, Development, Training and Services in State Of The Art Technology Platforms.

The World Health Organization (WHO) was established in 1948 as a specialized agency of the United Nations. The objective of WHO is attainment of the highest possible level of health by all people.

Because of their highly active metabolism, many tumors are susceptible to a special type of cell death, ferroptosis. Nevertheless, cancer cells often manage to escape this fate. Scientists at the German Cancer Research Center have now discovered a new mechanism by which normal as well as cancer cells protect themselves against ferroptosis. Knowledge of these molecular connections could provide new starting points for the treatment of tumors.

Neuromorphic computing system technology mimicking the human brain has emerged and overcome the limitation of excessive power consumption regarding the existing von Neumann computing method. A high-performance, analog artificial synapse device, capable of expressing various synapse connection strengths, is required to implement a semiconductor device that uses a brain information transmission method. This method uses signals transmitted between neurons when a neuron generates a spike signal.

Heron Therapeutics, Inc  a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs,  announced that the U.S. Food and Drug Administration (FDA) has approved APONVIE (aprepitant) injectable emulsion, for intravenous use for the prevention of postoperative nausea and vomiting (PONV) in adults.

Pfizer announced positive top-line results from its pivotal E.U. Phase 3 study in infants (NCT04546425) evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD), pneumonia, and acute otitis media caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes contained in the vaccine for the pediatric population.

Roche announced that the European Commission (EC) approved Vabysmo (faricimab) for the treatment of neovascular or wet age-related macular degeneration (nAMD) and visual impairment due to diabetic macular edema (DME). These retinal conditions are two of the leading causes of vision loss worldwide, affecting more than 40 million people.

Daewoong Pharmaceutical is carrying out its mission as a pharmaceutical company that safeguards the public health and shapes a healthy community by making quality drugs under its belief Giving Back to Society through Pharmaceuticals.

Pfizer is the world's premier biopharmaceutical company taking new approaches to better health.  We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

Eugia Steriles Private Limited is a 2 years 2 months old, private Indian Company, registered at Hyderabad.

Walk-In @ Production, Quality and Warehouse Departments

Department : Production, Warehouse Department

Shilpa Biologicals, having its R&D manufacturing facility in Dharwad, Karnataka is a biologics manufacturing & services company focussed on developing curative therapies with a cutting-edge team of scientists and committed professionals at the manufacturing floor. Our product pipeline focuses on immunology and haematology sectors with the goal of making it affordable to patients worldwide.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

SAIL, a Maharatna Company, and a leading steel-making company in India with a turnover of 49350 crores (FY 2012-13) is in the process of modernizing and expanding its production units, raw material resources and other facilities to maintain its dominant position in the Indian steel market. Bokaro Steel Plant, one of the modernised integrated steel plants of SAIL employing a motivated workforce of around 18000 employees is producer of HR Coils/Sheets/Plates, CR Coils/ Sheets, GP Sheets/Coils.

The National Institute of Pharmaceutical Education & Research (NIPER), SAS Nagar is an autonomous Institute of National importance set up by the Government of India, Ministry of Chemicals & Fertilizers by an Act of Parliament, to impart higher education and undertake advanced research in the field of Pharmaceutical sciences, technology and management.

Post : Technical Supervisor Grade-II/Scientist Grade-II

Torrent Pharma, the flagship company of Torrent Group, is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestina, diabetology, anti-infective and pain management segments. Torrent Pharma has a strong international presence spanning over 70 countries with over 1200 product registrations.

The wave of globalization has propelled the expansion of Indian pharma sector. India is amongst the top 10 countries of the world, in terms of volume and value of Pharmaceutical products. Enthusiastic and entrepreneurial efforts have turned Gujarat into the hub of Pharma industry.  The innovative and translational approach of the Indian scientists resulted in paradigm shift from industrial age to knowledge enriched economy.